全文获取类型
收费全文 | 3709786篇 |
免费 | 309768篇 |
国内免费 | 13747篇 |
专业分类
耳鼻咽喉 | 50919篇 |
儿科学 | 118343篇 |
妇产科学 | 97265篇 |
基础医学 | 580713篇 |
口腔科学 | 102769篇 |
临床医学 | 331317篇 |
内科学 | 661229篇 |
皮肤病学 | 95213篇 |
神经病学 | 316950篇 |
特种医学 | 148561篇 |
外国民族医学 | 497篇 |
外科学 | 572432篇 |
综合类 | 113722篇 |
现状与发展 | 23篇 |
一般理论 | 2375篇 |
预防医学 | 309414篇 |
眼科学 | 85759篇 |
药学 | 259615篇 |
22篇 | |
中国医学 | 10128篇 |
肿瘤学 | 176035篇 |
出版年
2021年 | 55045篇 |
2020年 | 35076篇 |
2019年 | 57994篇 |
2018年 | 71420篇 |
2017年 | 54458篇 |
2016年 | 60257篇 |
2015年 | 74241篇 |
2014年 | 108507篇 |
2013年 | 173587篇 |
2012年 | 97175篇 |
2011年 | 97571篇 |
2010年 | 117735篇 |
2009年 | 122063篇 |
2008年 | 85368篇 |
2007年 | 88668篇 |
2006年 | 99636篇 |
2005年 | 94771篇 |
2004年 | 97419篇 |
2003年 | 87899篇 |
2002年 | 77757篇 |
2001年 | 120830篇 |
2000年 | 115129篇 |
1999年 | 111696篇 |
1998年 | 67009篇 |
1997年 | 64578篇 |
1996年 | 62573篇 |
1995年 | 58192篇 |
1994年 | 52349篇 |
1993年 | 48889篇 |
1992年 | 82936篇 |
1991年 | 79401篇 |
1990年 | 75943篇 |
1989年 | 74614篇 |
1988年 | 69448篇 |
1987年 | 68137篇 |
1986年 | 64934篇 |
1985年 | 64804篇 |
1984年 | 56580篇 |
1983年 | 51282篇 |
1982年 | 44753篇 |
1981年 | 41912篇 |
1980年 | 39511篇 |
1979年 | 48958篇 |
1978年 | 40955篇 |
1977年 | 36773篇 |
1976年 | 34074篇 |
1975年 | 32836篇 |
1974年 | 35532篇 |
1973年 | 34193篇 |
1972年 | 31687篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
IntroductionHip displacement is common in cerebral palsy (CP) and is related to the severity of neurological and functional impairment. It is a silent, but progressive disease, and can result in significant morbidity and decreased quality of life, if left untreated. The pathophysiology of hip displacement in CP is a combination of hip flexor-adductor muscle spasticity, abductor muscle weakness, and delayed weight-bearing, resulting in proximal femoral deformities and progressive acetabular dysplasia. Due to a lack of symptoms in the early stages of hip displacement, the diagnosis is easily missed. Awareness of this condition and regular surveillance by clinical examination and serial radiographs of the hips are the key to early diagnosis and treatment.Hip surveillance programmesSeveral population-based studies from around the world have demonstrated that universal hip surveillance in children with CP allows early detection of hip displacement and appropriate early intervention, with a resultant decrease in painful dislocations. Global hip surveillance models are based upon the patients’ age, functional level determined by the Gross Motor Function Classification system (GMFCS), gait classification, standardized clinical exam, and radiographic indices such as the migration percentage (MP), as critical indicators of progressive hip displacement.ConclusionDespite 25 years of evidence showing the efficacy of established hip surveillance programmes, there is poor awareness among healthcare professionals in India about the importance of regular hip surveillance in children with CP. There is a need for professional organizations to develop evidence-based guidelines for hip surveillance which are relevant to the Indian context. 相似文献
23.
24.
25.
26.
27.
28.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment. 相似文献
29.
30.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献